Skip to content
Screener

Danaher DHR North America — Sales

Other geography segments

High-growth markets
$1.96B+15.4%
Western Europe
$1.54B+2.2%
Other developed markets
$293M-0.3%

Similar metrics at other companies

GTL
GTLSNorth America — Sales
$415.1M-9.2%
Rockwell Automation logo
ROKNorth America — Sales
$1.48B+9.5%
Envista Holdings Corporation logo
NVSTNorth America — Sales
$364.7M+4.8%
Vontier logo
VNTNorth America — Sales
$550.8M+2.6%
Aebi Schmidt Holding logo
AEBINorth America — Sales
$337.32M+129%
Flowserve logo
FLSNorth America — Sales
$520.63M+0.4%

Other financials

Income statement

See full
Revenue$6.3B+5.5%
Gross profit$3.6B+2.5%
Operating income$1.1B+48.3%
Net income$870.0M+56.8%
EPS (diluted)$1.23+59.7%

Balance sheet

See full
Cash & equivalents$4.3B+47.0%
Total debt$27.9B+50.1%
Total equity$52.6B+0.5%
Total assets$92.4B+13.2%

Cash flow

See full
Operating cash flow$1.5B+14.6%
CapEx$269.0M+8.5%
Free cash flow$1.3B+16.1%

Valuation

See full
Market cap$140.36B+0.4%
Enterprise value$163.87B+5.5%
P/E35.1×-5.9×
P/S5.6×-0.2×

Profitability

See full
Gross margin58.5%-1.1pp
Operating margin20.4%+2.0pp
Net margin15.9%+1.7pp
FCF margin21.8%+1.5pp

Returns & leverage

See full
Return on equity7.6%+1.0pp
Debt / equity0.5×+0.2×
Current ratio1.7×0.0×

Where this comes from

Reported directly by Danaher in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Danaher’s 10-Q, filed July 21, 2026.

Filed
Jul 20, 2026, 8:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000313616-26-000161
For the Three-Month Period Ended June 26, 2026:Biotechnology / For the Three-Month Period Ended June 26, 2026:Life SciencesDiagnosticsTotal
Geographical region:
North America(a)$583$759$1,132$2,474
Western Europe6894214301,540
Other developed markets(b)7412693293
High-growth markets(c)5745738111,958
Total$1,920$1,879$2,466$6,265
Revenue type:
Recurring$1,722$1,268$2,210$5,200

Item 1. Financial Statements

FAQ

What is Danaher's north america — sales?
Danaher (DHR) reported north america — sales of $2.47B in Q2 2026.
How has Danaher's north america — sales changed year-over-year?
Danaher's north america — sales increased by 1.5% year-over-year, from $2.44B to $2.47B.
What is the long-term trend for Danaher's north america — sales?
Over 4 years (2021 to 2025), Danaher's north america — sales has grown at a 1.4% compound annual growth rate (CAGR), from $9.8B to $10.36B.
What does north america — sales mean?
This metric represents the total revenue generated from products and services sold within the North American geographic region. It reflects the company's market penetration, demand strength, and commercial performance in its largest and most mature market. Changes in this figure indicate the effectiveness of regional sales strategies and the underlying economic health of the life sciences and diagnostics sectors in this territory.

Ask your AI about Danaher's north america — sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude